Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Cellectis S.A. Stock Price (Quote) NASDAQ:CLLS
$10.77 ( -4.10% ) Friday, 22nd Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $8.72 | $14.17 | Friday, 22nd Oct 2021 CLLS stock ended at $10.77. This is 4.1% less than the trading day before Thursday, 21st Oct 2021. During the day the stock fluctuated 4.51% from a day low at $10.65 to a day high of $11.13. |
| 90 days | $8.72 | $15.50 | |
| 52 weeks | $8.72 | $34.71 |
Historical Cellectis S.A. prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-22 | $11.13 | $11.13 | $10.65 | $10.77 | 88 983 |
| 2021-10-21 | $11.03 | $11.46 | $11.03 | $11.23 | 144 701 |
| 2021-10-20 | $10.92 | $11.00 | $10.75 | $10.94 | 95 466 |
| 2021-10-19 | $10.61 | $11.25 | $10.54 | $10.82 | 264 306 |
| 2021-10-18 | $10.69 | $11.06 | $10.41 | $10.50 | 166 420 |
| 2021-10-15 | $10.54 | $10.87 | $10.45 | $10.83 | 241 044 |
| 2021-10-14 | $9.88 | $10.84 | $9.78 | $10.70 | 585 563 |
| 2021-10-13 | $9.77 | $9.89 | $9.33 | $9.62 | 468 487 |
| 2021-10-12 | $9.15 | $9.35 | $9.10 | $9.15 | 266 652 |
| 2021-10-11 | $8.95 | $9.21 | $8.95 | $9.03 | 334 045 |
| 2021-10-08 | $10.11 | $10.11 | $8.72 | $9.11 | 2 180 252 |
| 2021-10-07 | $12.00 | $12.16 | $11.84 | $12.02 | 276 102 |
| 2021-10-06 | $12.23 | $12.43 | $11.83 | $11.97 | 160 199 |
| 2021-10-05 | $12.49 | $12.89 | $12.20 | $12.48 | 104 350 |
| 2021-10-04 | $12.49 | $12.55 | $12.07 | $12.17 | 232 230 |
| 2021-10-01 | $12.62 | $12.70 | $12.25 | $12.69 | 121 627 |
| 2021-09-30 | $12.65 | $13.12 | $12.60 | $12.61 | 141 840 |
| 2021-09-29 | $13.07 | $13.24 | $12.37 | $12.63 | 152 457 |
| 2021-09-28 | $13.63 | $13.63 | $12.96 | $12.96 | 109 828 |
| 2021-09-27 | $13.57 | $13.74 | $13.24 | $13.51 | 98 177 |
| 2021-09-24 | $13.70 | $13.93 | $13.22 | $13.41 | 90 034 |
| 2021-09-23 | $13.85 | $13.93 | $13.55 | $13.81 | 95 308 |
| 2021-09-22 | $13.74 | $14.17 | $13.69 | $13.77 | 110 954 |
| 2021-09-21 | $13.59 | $14.10 | $13.51 | $13.60 | 101 749 |
| 2021-09-20 | $13.87 | $14.01 | $13.29 | $13.50 | 143 760 |
| 2021-09-17 | $13.68 | $14.49 | $13.65 | $14.43 | 171 641 |
| 2021-09-16 | $13.83 | $13.88 | $13.51 | $13.55 | 50 388 |
| 2021-09-15 | $13.80 | $14.04 | $13.60 | $14.00 | 50 819 |
| 2021-09-14 | $14.06 | $14.24 | $13.60 | $13.86 | 74 561 |
| 2021-09-13 | $14.40 | $14.57 | $13.87 | $14.30 | 113 178 |
| 2021-09-10 | $14.76 | $14.86 | $14.23 | $14.26 | 66 984 |
| 2021-09-09 | $14.63 | $15.24 | $14.61 | $14.87 | 89 821 |
| 2021-09-08 | $14.84 | $14.90 | $14.21 | $14.32 | 82 444 |
| 2021-09-07 | $15.36 | $15.40 | $14.70 | $14.99 | 110 454 |
| 2021-09-03 | $15.24 | $15.47 | $15.02 | $15.24 | 111 529 |
| 2021-09-02 | $15.28 | $15.50 | $15.07 | $15.33 | 135 844 |
| 2021-09-01 | $14.88 | $15.21 | $14.76 | $14.92 | 141 450 |
| 2021-08-31 | $14.77 | $14.81 | $14.32 | $14.38 | 146 120 |
| 2021-08-30 | $14.26 | $14.37 | $13.86 | $13.95 | 90 029 |
| 2021-08-27 | $13.81 | $14.40 | $13.72 | $14.27 | 134 902 |
| 2021-08-26 | $13.48 | $13.87 | $13.36 | $13.38 | 71 104 |
| 2021-08-25 | $13.40 | $13.90 | $13.16 | $13.55 | 97 774 |
| 2021-08-24 | $13.48 | $13.60 | $13.12 | $13.27 | 76 881 |
| 2021-08-23 | $12.76 | $13.72 | $12.70 | $13.48 | 222 460 |
| 2021-08-20 | $11.99 | $12.82 | $11.94 | $12.47 | 168 018 |
| 2021-08-19 | $12.47 | $12.60 | $11.88 | $11.94 | 175 517 |
| 2021-08-18 | $12.52 | $12.95 | $12.42 | $12.61 | 111 203 |
| 2021-08-17 | $12.34 | $12.54 | $11.93 | $12.33 | 216 773 |
| 2021-08-16 | $12.52 | $12.70 | $12.04 | $12.59 | 240 373 |
| 2021-08-13 | $12.83 | $12.89 | $12.52 | $12.52 | 101 368 |
Cellectis S.A., a gene-editing company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. Its lead product candidate is UCART19, an allogeneic T-cell product candidate for the treatment of CD19 expressing hematologic malignancies which develop in acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia. The companys products also include UCART1... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
